This compound is a deuterium-labeled derivative of abiraterone, an active pharmaceutical ingredient used in the manufacturing of androgen biosynthesis inhibitors. Its structure incorporates multiple deuterium atoms at specific positions on the pyridine ring, which is characteristic of isotopically labeled compounds employed in pharmaceutical research and development.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Abiraterone Acetate-d4
pharmaceutical raw material
Trans-menaquinone 7
pharmaceutical raw material
Oxaprozin
pharmaceutical raw material
VCP-Eribulin
pharmaceutical raw material
[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]methyl N-[(2S)-2-hydroxy-3-[(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-21-methoxy-14-methyl-8,15-dimethylidene-24-oxo-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-20-yl]propyl]carbamate
pharmaceutical raw material
Abiraterone
pharmaceutical raw material
Abiraterone Impurity 35
pharmaceutical intermediate
3-Deoxy-3-chloroabiraterone (Mixture of Diastereomers)
pharmaceutical raw material
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol
GZOSMCIZMLWJML-UQHOXKPTSA-N
[2H]C1=C(C(=C(N=C1[2H])[2H])C2=CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O)C)C)[2H]
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.